Helping your patients understand the importance of a retinal health check.
455 million people worldwide have diabetes and diabetic retinopathy (DR) is the fourth leading cause of blindness in the world.
Join us in raising awareness of the importance of frequent vision screenings and retinal health checks.
Do your patients know?
Please enter a headline
Diabetic retinopathy is the cause of visual impairment for 4.2 million people globally.
Only half of all people with diabetes get an annual comprehensive dilated eye exam.
Adults age 50+ with diabetes are at a higher risk for developing diabetic retinopathy.
Early detection, timely treatment and appropriate follow-up care can reduce the risk of severe vision loss by 95%.
Help your patients understand what diabetic retinopathy looks like
The early stages of diabetic retinopathy usually have no symptoms. The disease often progresses unnoticed until bleeding occurs and affects vision. The lack of prompt or routine retinal health checks increases the risk of permanent vision loss. If diabetic macular edema (DME) occurs, it can result in blurred vision.
Help protect your patients' vision. Remind them of these 5 simple steps recommended by the National Eye Institute:
The National Eye Institute recommends five simple steps to help manage diabetes:
- Take your medications as prescribed by your doctor.
- Reach and maintain a healthy weight
- Add more physical activity to your daily routine
- Control your ABCs--A1C, blood pressure and cholesterol levels
- Kick the smoking habit
"If you have diabetes, keep your health on TRACK" by National Eye Health Education Program (NEHEP) is licensed under CC BY 4.0
Diabetic Retinopathy:
A Multi-Specialty Perspective
Clinicians across specialties agree that dialogue and continuous communication between primary care physicians, endocrinologists, ophthalmologists and optometrists are crucial for the management of diabetes.
A team-based approach to DR management
Diabetes is a "head to toe" disease that requires constant monitoring and management. The onset of diabetes may often affect multiple body systems, including vision. The reverse may also be true. The onset of diabetic retinopathy or diabetic nephropathy is often the first indication that the patient is diabetic. This calls for a multi-specialty approach to the management of diabetes.
Watch four clinicians from across multiple specialties discuss the importance and advantages of a team-based approach to diabetes care management.
The value of OCTA in the
management of DR
CIRRUS™ AngioPlex® OCT Angiography (OCTA) technology has created a new era in both Optical Coherence Tomography (OCT) and angiography. OCTA provides a non-invasive method that aids in the diagnosis and management of vascular diseases, the benefits of which are still being explored.
In this video, Amir H. Kashani, MD, PhD, describes why diabetic retinopathy may be the perfect model for understanding the potential role of OCT angiography in diagnosing, grading and managing retinal and macular pathology.
Managing diabetic eye disease with confidence
ZEISS diagnostic solutions
Path-breaking innovations in imaging have provided eye care clinicians valuable tools that are transforming patient care today. Take a look at how Aaron Lech, OD, FAAO, implemented the baseline retinal health check at his practice with Optical Coherence Tomography (OCT).
Optimize your diabetic
patient care and management
Must-have technology for your practice.
They say that seeing is believing. For diabetic patients, early detection is the key to successful disease management. By integrating into their practice advanced imaging technologies like OCT Angiography and Ultra-Widefield Fundus Imaging, clinicians now have ability to manage diabetic eye diseases earlier, quicker and with more confidence. The result—getting ahead of the problem and setting up your patient for a better outcome.
Optical Coherence Tomography (OCT)
CIRRUS™ OCT with AngioPlex allows for the visualization of both vascular and structural information from a single, non-invasive scan, making visualization of microvasculature of the retina a routine part of everyday care.
Ultra-Widefield
Fundus Imaging
CLARUS™ 500, next generation ultra-widefield fundus imaging from ZEISS is the first system to provide true color and clarity in an ultra-wide field of view—from the posterior pole to the far periphery.
Source:
National Eye Institute
https://nei.nih.gov/nehep/ndm
https://nei.nih.gov/health/diabetic/retinopathy
This is a code assigned to all external communications materials, to assist in tracking and monitoring during the internal approval process.